CVE-2023-22022 in Health Sciences Sciences Data Management Workbench
Summary
by MITRE • 07/19/2023
Vulnerability in the Oracle Health Sciences Sciences Data Management Workbench product of Oracle Health Sciences Applications (component: Blinding Functionality). Supported versions that are affected are 3.1.0.2, 3.1.1.3 and 3.2.0.0. Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise Oracle Health Sciences Sciences Data Management Workbench. Successful attacks of this vulnerability can result in unauthorized access to critical data or complete access to all Oracle Health Sciences Sciences Data Management Workbench accessible data. CVSS 3.1 Base Score 6.5 (Confidentiality impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:N/A:N).
VulDB is the best source for vulnerability data and more expert information about this specific topic.
Analysis
by VulDB Data Team • 08/13/2023
The vulnerability identified as CVE-2023-22022 affects the Oracle Health Sciences Data Management Workbench, specifically within its Blinding Functionality component. This critical security flaw exists in versions 3.1.0.2, 3.1.1.3, and 3.2.0.0 of the Oracle Health Sciences Applications suite. The vulnerability operates as a privilege escalation issue that allows attackers with low privileges to gain unauthorized access to sensitive data through network-based attacks. The CVSS score of 6.5 indicates a high severity threat with significant confidentiality impact, while the vector analysis shows network accessibility with low attack complexity and no user interaction required. This vulnerability represents a serious concern for healthcare organizations that rely on the secure handling of patient data and clinical research information.
The technical flaw stems from insufficient access controls within the blinding functionality of the data management workbench, which is designed to anonymize patient data for research purposes. Attackers can exploit this weakness by leveraging HTTP network connections to bypass normal authentication and authorization mechanisms. The vulnerability allows unauthorized access to critical data that should remain protected, potentially exposing sensitive patient information, clinical trial data, and research findings. The lack of proper input validation and access control checks within the blinding process creates an exploitable path that enables attackers to view or manipulate data that should only be accessible to authorized personnel with appropriate clearance levels.
The operational impact of this vulnerability extends beyond simple data exposure, as it compromises the integrity and confidentiality of healthcare research data within the Oracle Health Sciences ecosystem. Organizations utilizing this software may face regulatory compliance violations under HIPAA, GDPR, and other healthcare data protection frameworks. The vulnerability's potential for complete access to all accessible data means that attackers could potentially modify or exfiltrate entire datasets, undermining the trustworthiness of clinical research results and patient privacy protections. Security incidents resulting from this vulnerability could lead to significant financial penalties, legal consequences, and reputational damage for healthcare institutions and pharmaceutical companies relying on the platform.
Organizations should immediately implement mitigations including network segmentation to limit access to the affected system, applying the latest Oracle security patches, and implementing additional authentication controls for the blinding functionality. The vulnerability aligns with CWE-284 (Improper Access Control) and may be categorized under ATT&CK technique T1078 (Valid Accounts) and T1566 (Phishing) as attackers might attempt to leverage compromised credentials. Regular security monitoring and access control reviews should be implemented to detect potential exploitation attempts. Organizations must also consider implementing data loss prevention solutions and network-based intrusion detection systems to monitor for unauthorized access attempts to the vulnerable component. The security posture of healthcare organizations should be strengthened through comprehensive vulnerability management programs that include regular security assessments of all healthcare information systems and adherence to industry best practices for protecting sensitive medical data.